186 related articles for article (PubMed ID: 21514447)
1. Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.
Arbini AA; Greco M; Yao JL; Bourne P; Marra E; Hsieh JT; di Sant'agnese PA; Moro L
Am J Pathol; 2011 May; 178(5):2367-76. PubMed ID: 21514447
[TBL] [Abstract][Full Text] [Related]
2. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
[TBL] [Abstract][Full Text] [Related]
3. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
4. High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.
Šimečková Š; Kahounová Z; Fedr R; Remšík J; Slabáková E; Suchánková T; Procházková J; Bouchal J; Kharaishvili G; Král M; Beneš P; Souček K
Sci Rep; 2019 Apr; 9(1):5695. PubMed ID: 30952903
[TBL] [Abstract][Full Text] [Related]
5. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.
Moro L; Arbini AA; Marra E; Greco M
J Biol Chem; 2006 Aug; 281(31):22100-22107. PubMed ID: 16754685
[TBL] [Abstract][Full Text] [Related]
7. Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.
Jiang J; Pan Y; Regan KM; Wu C; Zhang X; Tindall DJ; Huang H
Prostate; 2012 Feb; 72(2):225-32. PubMed ID: 21630295
[TBL] [Abstract][Full Text] [Related]
8. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
9. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
[TBL] [Abstract][Full Text] [Related]
10. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
Moro L; Arbini AA; Marra E; Greco M
J Biol Chem; 2005 Jun; 280(23):22482-91. PubMed ID: 15805113
[TBL] [Abstract][Full Text] [Related]
12. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
13. Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
Cancer Sci; 2008 Mar; 99(3):553-63. PubMed ID: 18167127
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
[TBL] [Abstract][Full Text] [Related]
16. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.
Drobnjak M; Melamed J; Taneja S; Melzer K; Wieczorek R; Levinson B; Zeleniuch-Jacquotte A; Polsky D; Ferrara J; Perez-Soler R; Cordon-Cardo C; Pagano M; Osman I
Clin Cancer Res; 2003 Jul; 9(7):2613-9. PubMed ID: 12855638
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
[TBL] [Abstract][Full Text] [Related]
19. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
[TBL] [Abstract][Full Text] [Related]
20. Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.
Francis JC; McCarthy A; Thomsen MK; Ashworth A; Swain A
PLoS Genet; 2010 Jun; 6(6):e1000995. PubMed ID: 20585617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
